We translate condensate biology into much-needed medicines.
We believe that biomolecular condensates
- create dynamic, liquid compartments in cells
- concentrate important chemistry in space and time
- are central to neurodegeneration, cancer, and other diseases
- will help Dewpoint discover important new drugs
A new biology
Our founders and advisors explain how condensates drive cell function and solve biological mysteries.
Stressed cells form condensates.
Our impact
Condensates play a critical role in a wide range of important, once-intractable diseases. Dewpoint develops drugs that exploit this biology to hit “undruggable” targets.
Opportunities that excite us
- Neurodegeneration
- Cancer
- Inflammation
- Infectious disease
- Metabolic disease
- Rare genetic disorders
Collectively we have...
300+
Published papers
90+
Patents
175+
Years in pharma
About us
We are a dynamic young biotech company based in Boston and Dresden that is translating brand-new insights about biomolecular condensates into treatments for the toughest diseases.
Boston Team Dresden Team
Latest News
Join our team
We are looking for passionate—and compassionate—scientists across a diverse set of scientific disciplines, including cell biology, high content cell imaging, biophysics, and proteomics. If that’s you we’d love to hear from you, even if there’s not currently an opening that looks like a perfect fit.
Latest Openings
- Data Scientist, Drug DiscoveryBoston, MA, USA
- Data Scientist, Drug Discovery (m/f/d)Dresden, Germany
- Director/VP for Chemistry (m/f/d)Berlin, Germany
- Interested in joining Dewpoint Boston?Boston, MA, USA
- Interested in joining Dewpoint Dresden?Dresden, Germany
- Research Associate - Assay Development (m/f/d)Dresden, Germany
- Research Associate(m/f/d) – New Target DiscoveryDresden, Germany
- Scientist PhD (m/f/d) – New Target DiscoveryDresden, Germany
- Screening / Automation Research Associate, Drug DiscoveryBoston, MA, USA
- Screening / Automation Research Associate, Drug Discovery (m/f/d)Dresden, Germany
- Screening ScientistBoston, MA
- Target ID / Interactome Mapping -- BS/MS AssociateBoston, MA, USA
- Target ID/Interactome Mapping-Group Leader PhDBoston, MA
- Target ID / Interactome Mapping -- PhD ScientistBoston, MA, USA
Fascinating science
Mind-bending results that utterly change how we understand disease? That’s a Tuesday—and everybody on the team has a real say on what we do Wednesday.
Good folks
You know that jerk who made life in your last lab miserable? He doesn’t work here. But some of the nicest, smartest, goofiest people you’ll ever meet do.
Ambitious agenda
Interested in changing the way drug discovery is done while producing a whole new generation of treatments? Let's work together to make it happen.
Condensates.com
News, events, resources, and insights by and for the condensate community.
Visit siteCurated by 
-
Multivalent proteins rapidly and reversibly phase-separate upon osmotic cell volume change
May 25, 2020
-
Phase-separated Bacterial Ribonucleoprotein Bodies Organize mRNA Decay
May 25, 2020
-
Managing Hyperosmotic Stress Through Phase Separation
May 22, 2020
-
Recent Advances in Complex Coacervation Design From Macromolecular Assemblies and Emerging Applications
May 21, 2020
-
Synergistic Interactions Between Cajal Bodies and the miRNA Processing Machinery
May 21, 2020
-
Single-Protein Collapse Determines Phase Equilibria of a Biological Condensate
May 20, 2020
-
Comparative Analysis of MACROD1, MACROD2 and TARG1 Expression, Localisation and Interactome
May 20, 2020
-
AMPK-mediated Formation of Stress Granules Is Required for Dietary Restriction-Induced Longevity in Caenorhabditis Elegans
May 20, 2020
-
Integrated multi-omics reveals common properties underlying stress granule and P-body formation
May 20, 2020
-
Suppression of liquid-liquid phase separation by 1,6-hexanediol partially compromises the 3D genome organization in living cells
May 19, 2020